Back to results
US 11,377,491 B2Granted
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer
AssigneeBoard of Regents, The University of Texas System
InventorsX. Charlene Liao, Qiang Liu, Zhiqiang An, Ningyan Zhang, Xun Gui, Chengcheng Zhang, Mi Deng, Jingjing Xie
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to antibodies binding to LAIR 1 and their treating cancer, inflammation, immune-related diseases or transplantation.
Claims10
An isolated monoclonal antibody or an antigen-binding fragment thereof comprising
- (a) a heavy chain variable region comprising the following complementary determining regions (CDRs):
- a heavy chain CDR1 that is a CDR1 in SEQ ID NO:
- 1, 15, 29, 43, 57, 71, 85, 99, 113, 127, 141, 155, 169, 183, 197, 211, 225, 239, 253, 267, 281, 295, 309, 323, 337, 351, 365, 379, 393, 407, 421, 435, 449, 463, 477, 491, 505 or 519, a heavy chain CDR2 that is a CDR2 in SEQ ID NO:
- 1, 15, 29, 43, 57, 71, 85, 99, 113, 127, 141, 155, 169, 183, 197, 211, 225, 239, 253, 267, 281, 295, 309, 323, 337, 351, 365, 379, 393, 407, 421, 435, 449, 463, 477, 491, 505 or 519, and a heavy chain CDR3 that is a CDR3 in SEQ ID NO:
- 1, 15, 29, 43, 57, 71, 85, 99, 113, 127, 141, 155, 169, 183, 197, 211, 225, 239, 253, 267, 281, 295, 309, 323, 337, 351, 365, 379, 393, 407, 421, 435, 449, 463, 477, 491, 505 or 519;
- and
- (b) a light chain variable region comprising the following CDRs:
- a light chain CDR1 that is a CDR1 in SEQ ID NO:
- 2, 16, 30, 44, 58, 72, 86, 100, 114, 128, 142, 156, 170, 184, 198, 212, 226, 240, 254, 268, 282, 296, 310, 324, 338, 352, 366, 380, 394, 408, 422, 436, 450, 464, 478, 492, 506 or 520, a light chain CDR2 that is a CDR2 in SEQ ID NO:
- 2, 16, 30, 44, 58, 72, 86, 100, 114, 128, 142, 156, 170, 184, 198, 212, 226, 240, 254, 268, 282, 296, 310, 324, 338, 352, 366, 380, 394, 408, 422, 436, 450, 464, 478, 492, 506 or 520, and a light chain CDR3 that is a CDR3 in SEQ ID NO:
- 2, 16, 30, 44, 58, 72, 86, 100, 114, 128, 142, 156, 170, 184, 198, 212, 226, 240, 254, 268, 282, 296, 310, 324, 338, 352, 366, 380, 394, 408, 422, 436, 450, 464, 478, 492, 506 or 520.
8 more elements
An isolated monoclonal antibody or an antigen-binding fragment thereof comprising:
- (a) a heavy chain variable region having an amino acid sequence at least about 90% identical to SEQ ID NO:
- 1, 15, 29, 43, 57, 71, 85, 99, 113, 127, 141, 155, 169, 183, 197, 211, 225, 239, 253, 267, 281, 295, 309, 323, 337, 351, 365, 379, 393, 407, 421, 435, 449, 463, 477, 491, 505 or 519;
- and
- (b) a light chain variable region having an amino acid sequence at least about 90% identical to SEQ ID NO:
- 2, 16, 30, 44, 58, 72, 86, 100, 114, 128, 142, 156, 170, 184, 198, 212, 226, 240, 254, 268, 282, 296, 310, 324, 338, 352, 366, 380, 394, 408, 422, 436, 450, 464, 478, 492, 506 or 520.
2 more elements
Dependencies are inferred from the claim text.